Stockreport

Lyell Immunopharma Announces the Acceptance of Three Abstracts for Presentation at 2024 AACR Annual Meeting [Yahoo! Finance]

Lyell Immunopharma, Inc.  (LYEL) 
PDF company advancing a diverse pipeline of cell therapies for patients with solid tumors, announced that three abstracts of new nonclinical data have been accepted for pres [Read more]